VGXi Sign Deal to Manufacture DNA for the Consortium

Wednesday, May 14th 2008

Print this page

vgxi-logo.jpgVGXi Pharmaceuticals sign a multi-year production agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium.

VGXi Pharmaceuticals (Houston, TX) today announced that the company has signed a multi-year supply agreement to provide plasmid DNA to support the ongoing toxicology and clinical trials of the United Kingdom Cystic Fibrosis Gene Therapy Consortium.

signing.jpg

Deborah Gill signing the contract with VGXi in Baltimore at the ASGCT.


 

Sheep lung parenchyma (cell nuclei blue) transduced with an adenoviral vector (green).

 

A pellet of E.coli containing a plasmid expressing a pink fluorescent protein.